PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers
- Conditions
- Healthy
- Interventions
- Drug: Food Effect cohortDrug: CSF cohort
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2010-08-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 10
- Registration Number
- NCT01045863
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 10
- Registration Number
- NCT01045317
- Locations
- 🇬🇧
Pfizer Investigational Site, Ruddington Fields, Nottingham, United Kingdom
A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus
- First Posted Date
- 2010-01-08
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 50
- Registration Number
- NCT01044537
- Locations
- 🇺🇸
Dedicated Phase 1, Phoenix, Arizona, United States
🇺🇸West Coast Clinical Trials, LLC, Cypress, California, United States
🇺🇸Elite Research Institute, Miami, Florida, United States
A Study To Estimate The Relative Bioavailability Of PF-00258210 Administered Alone Or In Combination With PF-00610355
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2010-01-06
- Last Posted Date
- 2010-04-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 20
- Registration Number
- NCT01043276
- Locations
- 🇸🇬
Pfizer Investigational Site, Singapore, Singapore
Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients
- First Posted Date
- 2010-01-05
- Last Posted Date
- 2011-07-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 22
- Registration Number
- NCT01042236
- Locations
- 🇩🇰
Glostrup Hospital, Glostrup, Denmark
Cost Effectiveness Of Linezolid In Central America
- First Posted Date
- 2009-12-29
- Last Posted Date
- 2012-03-02
- Lead Sponsor
- Pfizer
- Registration Number
- NCT01040585
Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX
- Conditions
- Arthritis, Rheumatoid
- Interventions
- Drug: Disease-modifying antirheumatic drug
- First Posted Date
- 2009-12-25
- Last Posted Date
- 2018-04-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 956
- Registration Number
- NCT01039688
- Locations
- 🇨🇦
Manitoba Clinic, Winnipeg, Manitoba, Canada
🇺🇸University of California Los Angeles (UCLA), Los Angeles, California, United States
🇺🇸Mountain State Clinical Research, Clarksburg, West Virginia, United States
Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty
- First Posted Date
- 2009-12-23
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 41
- Registration Number
- NCT01037985
- Locations
- 🇺🇸
Barnes Jewish West County Hospital, Saint Louis, Missouri, United States
🇺🇸Body Aesthetic Plastic Surgery, Saint Louis, Missouri, United States
🇺🇸Scripps medical, La Jolla, California, United States
Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery
- First Posted Date
- 2009-12-23
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 25
- Registration Number
- NCT01037413
- Locations
- 🇺🇸
Body Aesthetic Plastic Surgery, Saint Louis, Missouri, United States
🇺🇸Scripps medical, La Jolla, California, United States
🇺🇸Northwestern University,Division of Plastic Surgery, Chicago, Illinois, United States
Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty
- First Posted Date
- 2009-12-23
- Last Posted Date
- 2021-09-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 30
- Registration Number
- NCT01038297
- Locations
- 🇺🇸
Northwestern University,Division of Plastic Surgery, Chicago, Illinois, United States
🇺🇸Body Aesthetic Plastic Surgery, Saint Louis, Missouri, United States